Perceptive Advisors LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Perceptive Advisors LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $10.3 Million - $12.4 Million	100,000 New	100,000 $12.1 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $11.2 Million - $15.2 Million	-100,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $10.7 Million - $15.2 Million	100,000 New	100,000 $421,000

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.